Search
for
Sort by
Research 241–270 of 294
- Design of Nanocrystalline Suspension of Dutasteride for Intramuscular Prolonged Delivery
- Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients
- Annurca Apple Polyphenols Protect Murine Hair Follicles from Taxane Induced Dystrophy and Hijacks Polyunsaturated Fatty Acid Metabolism toward β-Oxidation
- Low Intensity Ultrasound as an Antidote to Taxane/Paclitaxel-induced Cytotoxicity
- Taxane-induced alopecia: A historical review of patients with ovarian or breast cancer treated with with paclitaxel, docetaxel or paclitaxel poliglumex
- Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer
- Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies
- 1400 Low-intensity ultrasound protects human scalp hair follicles from taxane-induced toxicity
- 506 Taxane chemotherapy promotes aging of human hair follicles and their stem cells
- 803 Taxane chemotherapy induces epigenetic changes and premature senescence in human scalp hair follicles
- Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study
- Safety and efficacy of low-dose metronomic cyclophosphamide plus vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.
- Alopécia Permanente Pós-Quimioterapia com Resposta Favorável ao Minoxidil Tópico
- Prostate cancer update: 2007
- Mucocutaneous side effects of antineoplastic chemotherapy
- Persistent chemotherapy-induced alopecia: updates in diagnosis and treatment persistent chemotherapy induced alopecia: an updated approach
- Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique
- ISID1403 - Melatonin protects K15+ human hair follicle stem cells against paclitaxel-induced damage ex vivo
- S1‐Guideline Cutaneous Angiosarcomas – Update 2021
- Prostate cancer update: 2007
- High incidence of severe hand–foot syndrome during capecitabine–docetaxel combination chemotherapy
- Docetaxel-induced Psoriasis
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Permanent chemotherapy-induced alopecia: Case report and review of the literature
- Low-level laser treatment accelerated hair regrowth in a rat model of chemotherapy-induced alopecia (CIA)
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Severe Unilateral Alopecia in a Long-Term Surviving Male Adolescent Glioblastoma Multiforme Patient
- Chemotoxicity in Carcinoma Breast Patients - Its Incidence and Trends in Severity - An Observational Study
- Drug Reactions Affecting Hair: Diagnosis